Table 1.
Parameters | Klotho deficient mice | Klotho overexpression mice |
---|---|---|
Body weight | Showing growth retardation and becoming inactive and marantic at 3 to 4 weeks of age (Kuro-o et al., 1997). | Normal (Kurosu et al., 2005) |
Average lifespan | About 2 months (vs 2.5 to 3 years for wild-type mice) (Kuro-o et al., 1997). | About 20–30% longer than wild-type mice (Kurosu et al., 2005). |
Maximal lifespan | Less than 100 days (Kuro-o et al., 1997). | More than 936 days (Kurosu et al., 2005). |
Insulin | Decreased insulin secretion and enhanced insulin sensitivity (Kuro-o et al., 1997). | Increased resistance to insulin and IGF-1 signaling (Kurosu et al., 2005). |
Phosphorus homeostasis | Hyperphosphatemia (Kuro-o et al., 1997). | Normal (Kurosu et al., 2005). |
Calcium homeostasis | Ectopic calcification in various organs (Kuro-o et al., 1997). | Normal (Kurosu et al., 2005). |
Diseases | Hypogonadism, infertility, premature thymic involution, ectopic calcification, decreased bone mineral density, skin and muscle atrophy, ataxia, emphysema, cognitive impairment, hearing loss, vascular calcification (Kuro-o et al., 1997). Reduction of NO synthesis in vascular endothelial cells (Saito et al., 1998). | Protection of the angiotensin II-induced renal damage (Mitani et al., 2002). Suppression of H2O2-induced apoptosis and cellular senescence in vascular cells (Ikushima et al., and 2006). Reduction of risk factors for atherosclerosis. Enhanced hearing ability (Bektas et al., 2004) |